Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Mosca

Showing results (41-50 of 68) with videos related to

Pageof 7
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 16, 2001
Human mesenchymal stem cells maintain transgene expression during expansion and differentiationK Lee, M K Majumdar, D Buyaner, et al.
Stem Cells Translational Medicine|April 18, 2013
Comparison of drug and cell-based delivery: engineered adult mesenchymal stem cells expressing soluble tumor necrosis factor receptor II prevent arthritis in mouse and rat animal modelsLinda N Liu, Gang Wang, Kyle Hendricks, et al.
Journal of Virology|June 8, 2007
Development of smallpox vaccine candidates with integrated interleukin-15 that demonstrate superior immunogenicity, efficacy, and safety in miceLiyanage P Perera, Thomas A Waldmann, Joseph D Mosca, et al.
Journal of Virology|August 1, 1993
A major transactivator of varicella-zoster virus, the immediate-early protein IE62, contains a potent N-terminal activation domainL P Perera, J D Mosca, W T Ruyechan, et al.
Human Cell|March 1, 1997
Human mesenchymal stem cells respond to fibroblast growth factorsC van den Bos, J D Mosca, J Winkles, et al.
Journal of Virology|April 1, 1994
Varicella-zoster virus open reading frame 4 encodes a transcriptional activator that is functionally distinct from that of herpes simplex virus homology ICP27L P Perera, S Kaushal, P R Kinchington, et al.
Biochemistry|August 16, 1983
2',5'-oligoadenylate synthetase from cutaneous T-cell lymphoma: biosynthesis, identification, quantitation, molecular size of the 2',5'-oligoadenylates, and inhibition of protein synthesisR J Suhadolnik, M B Flick, J D Mosca, et al.
Journal of Virology|November 1, 1995
Herpes simplex virus trans-regulatory protein ICP27 stabilizes and binds to 3' ends of labile mRNAC R Brown, M S Nakamura, J D Mosca, et al.
AIDS Research and Human Retroviruses|September 1, 1993
Consequences of human immunodeficiency virus type 1 superinfection of chronically infected cellsJ H Kim, J D Mosca, M T Vahey, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|August 1, 1996
Inhibition of HIV replication by sense and antisense rev response elements in HIV-based retroviral vectorsJ H Kim, R J McLinden, J D Mosca, et al.
Pageof 7

Showing results (41-50 of 68) with videos related to

Sort By:
Pageof 7
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 16, 2001
Human mesenchymal stem cells maintain transgene expression during expansion and differentiationK Lee, M K Majumdar, D Buyaner, et al.
Stem Cells Translational Medicine|April 18, 2013
Comparison of drug and cell-based delivery: engineered adult mesenchymal stem cells expressing soluble tumor necrosis factor receptor II prevent arthritis in mouse and rat animal modelsLinda N Liu, Gang Wang, Kyle Hendricks, et al.
Journal of Virology|June 8, 2007
Development of smallpox vaccine candidates with integrated interleukin-15 that demonstrate superior immunogenicity, efficacy, and safety in miceLiyanage P Perera, Thomas A Waldmann, Joseph D Mosca, et al.
Journal of Virology|August 1, 1993
A major transactivator of varicella-zoster virus, the immediate-early protein IE62, contains a potent N-terminal activation domainL P Perera, J D Mosca, W T Ruyechan, et al.
Human Cell|March 1, 1997
Human mesenchymal stem cells respond to fibroblast growth factorsC van den Bos, J D Mosca, J Winkles, et al.
Journal of Virology|April 1, 1994
Varicella-zoster virus open reading frame 4 encodes a transcriptional activator that is functionally distinct from that of herpes simplex virus homology ICP27L P Perera, S Kaushal, P R Kinchington, et al.
Biochemistry|August 16, 1983
2',5'-oligoadenylate synthetase from cutaneous T-cell lymphoma: biosynthesis, identification, quantitation, molecular size of the 2',5'-oligoadenylates, and inhibition of protein synthesisR J Suhadolnik, M B Flick, J D Mosca, et al.
Journal of Virology|November 1, 1995
Herpes simplex virus trans-regulatory protein ICP27 stabilizes and binds to 3' ends of labile mRNAC R Brown, M S Nakamura, J D Mosca, et al.
AIDS Research and Human Retroviruses|September 1, 1993
Consequences of human immunodeficiency virus type 1 superinfection of chronically infected cellsJ H Kim, J D Mosca, M T Vahey, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|August 1, 1996
Inhibition of HIV replication by sense and antisense rev response elements in HIV-based retroviral vectorsJ H Kim, R J McLinden, J D Mosca, et al.
Pageof 7